Skip to content

Catalys Pacific, LLC

Follow

13F filer, CIK 2011385, TOKYO, Japan

Catalys Pacific, LLC reported $229,453,865 across 2 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-05.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-090867

Period
2026-06-30
Reported value
$229M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001104659-26-090867, largest first. % of portfolio is the value over $229,453,865, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,644,579 shares; 2024Q4: 8,644,579 shares; 2025Q1: 8,903,838 shares; 2025Q2: 8,903,838 shares; 2025Q3: 8,903,838 shares; 2025Q4: 7,903,838 shares; 2026Q1: 7,903,838 shares; 2026Q2: 7,903,838 shares 7,903,838$213M92.94%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,122,572 shares; 2024Q4: 1,167,114 shares; 2025Q1: 1,167,114 shares; 2025Q2: 1,167,114 shares; 2025Q3: 1,167,114 shares; 2025Q4: 1,429,014 shares; 2026Q1: 1,493,854 shares; 2026Q2: 1,493,854 shares 1,493,854$16.2M7.06%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-090867 base2026-08-05acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001104659-26-090867 Quarter ended 2026-06-302026-08-05acceptance time not in the bulk data set
13F-HR 0001104659-26-060911 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001104659-26-012485 Quarter ended 2025-12-312026-02-10acceptance time not in the bulk data set
13F-HR 0001104659-25-112029 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001104659-25-077546 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR/A 0001104659-25-077579 Quarter ended 2025-03-312025-08-13acceptance time not in the bulk data set
13F-HR 0001104659-25-048317 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001104659-25-013740 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001104659-24-116643 Quarter ended 2024-09-302024-11-12acceptance time not in the bulk data set
13F-HR 0001104659-24-088833 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001104659-24-060699 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001104659-24-022986 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set